NMR applications for identifying β -TrCP protein-ligand interactions

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 4, 2011, Pages 283-297

  Pons, J ^a,b   Tanchou, V ^b   Girault, J P ^a   Bertho, G ^a   Evrard Todeschi, N ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CEA VALRHO Centre de Marcoule   (France)

Author keywords

TrCP complex; Binding fragment; Docking; Epitope mapping; Phosphorylated peptide; STD NMR; WaterLOGSY

Indexed keywords

BETA CATENIN; BETA TRANSDUCIN REPEAT CONTAINING PROTEIN; LIGAND; MALTOSE BINDING PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; DISSOCIATION CONSTANT; HUMAN; LIGAND BINDING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN MOTIF;

BETA-TRANSDUCIN REPEAT-CONTAINING PROTEINS; COMPUTER SIMULATION; HUMANS; LIGANDS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 79954494869     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955711795305344     Document Type: Article

References (89)

1. Shuker, S.B.; Hajduk, P.J.; Meadows, R.P.; Fesik, S.W. Discovering high-affinity ligands for proteins: SAR by NMR, Science, 1996, 274, 1531-4.
2. Chen, A.; Shapiro, M.J. NOE pumping: A novel NMR technique for identification of compounds with binding affinity to macromolecules, J. Am. Chem. Soc., 1998, 120, 10258-59.
3. Chen, A.; Shapiro, M.J. NOE pumping. 2. A high-throughput method to determine compounds with binding affinity to macromolecules by NMR, J. Am. Chem. Soc., 2000, 122, 414-15.
4. Dalvit, C.; Pevarello, P.; Tato, M.; Veronesi, M.; Vulpetti, A.; Sundstrom, M. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water, J. Biomol. NMR, 2000, 18, 65-8.
5. Mayer, M.; Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy, Angew. Chem. Int. Ed. Engl., 1999, 38, 1784-88.
6. Bertho, G.; Gharbi-Benarous, J.; Delaforge, M.; Girault, J.P. Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: correlation between antibiotic activities and bound conformations, Bioorg. Med. Chem., 1998, 6, 209-21.
7. Dalvit, C.; Fogliatto, G.; Stewart, A.; Veronesi, M.; Stockman, B. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability, J. Biomol. NMR, 2001, 21, 349-59.
8. Mayer, M.; Meyer, B. Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor, J. Am. Chem. Soc., 2001, 123, 6108-17.
9. Klein, J.; Meinecke, R.; Mayer, M.; Meyer, B. Detecting binding affinity to immobilized receptor proteins in compound libraries by HR-MAS STD NMR, J. Am. Chem. Soc., 1999, 121, 5336-37.
10. Wang, Y.S.; Liu, D.; Wyss, D.F. Competition STD NMR for the detection of high-affinity ligands and NMR-based screening, Magn. Reson. Chem., 2004, 42, 485-9.
11. Ciechanover, A. The ubiquitin-proteasome pathway: on protein death and cell life, EMBO J., 1998, 17, 7151-60.
12. Hershko, A.; Ciechanover, A. The ubiquitin system, Annu. Rev. Biochem., 1998, 67, 425-79.
13. Laney, J.D.; Hochstrasser, M. Substrate targeting in the ubiquitin system, Cell, 1999, 97, 427-30.
14. Wu, G.; Xu, G.; Schulman, B.A.; Jeffrey, P.D.; Harper, J.W.; Pavletich, N.P. Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase, Mol. Cell, 2003, 11, 1445-56.
15. Coadou, G.; Gharbi-Benarous, J.; Megy, S.; Bertho, G.; Evrard-Todeschi, N.; Segeral, E.; Benarous, R.; Girault, J.P. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP, Biochemistry, 2003, 42, 14741-51.
16. Megy, S.; Bertho, G.; Gharbi-Benarous, J.; Evrard-Todeschi, N.; Coadou, G.; Segeral, E.; Iehle, C.; Quemeneur, E.; Benarous, R.; Girault, J.P. STD and TRNOESY NMR studies on the conformation of the oncogenic protein beta-catenin containing the phosphorylated motif DpSGXXpS bound to the beta-TrCP protein, J. Biol. Chem., 2005, 280, 29107-16.
17. Pons, J.; Evrard-Todeschi, N.; Bertho, G.; Gharbi-Benarous, J.; Sonois, V.; Benarous, R.; Girault, J.P. Structural studies on 24PIkappaBalpha peptide derived from a human IkappaB-alpha protein related to the inhibition of the activity of the transcription factor NF-kappaB, Biochemistry, 2007, 46, 2958-72.
18. Pons, J.; Evrard-Todeschi, N.; Bertho, G.; Gharbi-Benarous, J.; Tanchou, V.; Benarous, R.; Girault, J.P. Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin, Biochemistry, 2008, 47, 14-29.
19. Nallamsetty, S.; Austin, B.P.; Penrose, K.J.; Waugh, D.S. Gateway vectors for the production of combinatorially-tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli, Protein Sci., 2005, 14, 2964-71.
20. Marion, D.; Ikura, M.; Tschudin, R.; Bax, A. Rapid recording of 2D NMR spectra without phase cycling. Application to the study of hydrogen exchange in proteins, J. Magn. Reson., 1989, 85, 393-99.
21. Hwang, T.-L.; Shaka, A.J. Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients, J. Magn. Reson., 1995, 112, 275-79.
22. Piotto, M.; Saudek, V.; Sklenar, V. Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions, J. Biomol. NMR, 1992, 2, 661-5.
23. Xia, Y.; Legge, G.; Jun, K.Y.; Qi, Y.; Lee, H.; Gao, X. IP-COSY, a totally in-phase and sensitive COSY experiment, Magn. Reson. Chem., 2005, 43, 372-9.
24. Braunschweiler, L.; Ernst, R.R. Coherence Transfer by Isotropic Mixing: Application to Proton Correlation Spectroscopy, J. Magn. Reson., 1983, 53, 521-28.
25. Kumar, A.; Ernst, R.R.; Wuthrich, K. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules, Biochem. Biophys. Res. Commun., 1980, 95, 1-6.
26. Bothner-By, A.A.; Stevens, R.L.; Lee, J.T.; Warren, C.D.; Jeanloz, R.W. Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame, J. Am. Chem. Soc., 1984, 106, 811-13.
27. Bax, A.; Davis, D.G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy, J. Magn. Reson., 1985, 65, 355-60.
28. Bodenhausen, G.; Ruben, D.J. Natural Abundance Nitrogen-15 NMR by Enhanced Heteronuclear Spectroscopy, Chem. Phys. Lett., 1980, 69, 185-86.
29. Willker, W.; Leibfritz, D.; Kerssebaum, R.; Bermel, W. Gradient Selection in Inverse Heteronuclear Correlation Spectroscopy, Magn. Reson. Chem., 1993, 31, 287-92.
30. Bax, A.; Summers, M.F. 1H and 13C Assignments from Sensitivity-Enhanced Detection of Heteronuclear Multiple-Bond Connectivity by 2D Multiple Quantum NMR, J. Am. Chem. Soc., 1986, 108, 2093-94.
31. Shimotakahara, S.; Furihata, K.; Tashiro, M. Application of NMR screening techniques for observing ligand binding with a protein receptor, Magn. Reson. Chem., 2005, 43, 69-72.
32. Milton, M.J.; Thomas Williamson, R.; Koehn, F.E. Mapping the bound conformation and protein interactions of microtubule destabilizing peptides by STD-NMR spectroscopy, Bioorg. Med. Chem. Lett., 2006, 16, 4279-82.
33. Brunger, A.T.; Adams, P.D.; Clore, G.M.; DeLano, W.L.; Gros, P.; Grosse-Kunstleve, R.W.; Jiang, J.S.; Kuszewski, J.; Nilges, M.; Pannu, N.S.; Read, R.J.; Rice, L.M.; Simonson, T.; Warren, G.L. Crystallography & NMR system: A new software suite for macromolecular structure determination, Acta. Crystallogr. D. Biol. Crystallogr., 1998, 54, 905-21.
34. Linge, J.P.; Habeck, M.; Rieping, W.; Nilges, M. ARIA: automated NOE assignment and NMR structure calculation, Bioinformatics, 2003, 19, 315-6.
35. DeLano, W.L. The PyMOL Molecular Graphics System, on World Wide Web http://www.pymol.org, 2002.
36. Jain, A.N. Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine, J. Med. Chem., 2003, 46, 499-511.
37. Hart, M.; Concordet, J.P.; Lassot, I.; Albert, I.; del los Santos, R.; Durand, H.; Perret, C.; Rubinfeld, B.; Margottin, F.; Benarous, R.; Polakis, P. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell, Curr. Biol., 1999, 9, 207-10.
38. Kroll, M.; Margottin, F.; Kohl, A.; Renard, P.; Durand, H.; Concordet, J.P.; Bachelerie, F.; Arenzana-Seisdedos, F.; Benarous, R. Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP, J. Biol. Chem., 1999, 274, 7941-5.
39. Latres, E.; Chiaur, D.S.; Pagano, M. The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin, Oncogene, 1999, 18, 849-54.
40. Spencer, E.; Jiang, J.; Chen, Z.J. Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP, Genes Dev., 1999, 13, 284-94.
41. Winston, J.T.; Strack, P.; Beer-Romero, P.; Chu, C.Y.; Elledge, S.J.; Harper, J.W. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro, Genes Dev., 1999, 13, 270-83.
42. Yaron, A.; Hatzubai, A.; Davis, M.; Lavon, I.; Amit, S.; Manning, A.M.; Andersen, J.S.; Mann, M.; Mercurio, F.; Ben-Neriah, Y. Identification of the receptor component of the IkappaBalphaubiquitin ligase, Nature, 1998, 396, 590-4.
43. Margottin, F.; Bour, S.P.; Durand, H.; Selig, L.; Benichou, S.; Richard, V.; Thomas, D.; Strebel, K.; Benarous, R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif, Mol. Cell, 1998, 1, 565-74.
44. Besnard-Guerin, C.; Belaidouni, N.; Lassot, I.; Segeral, E.; Jobart, A.; Marchal, C.; Benarous, R. HIV-1 Vpu sequesters betatransducin repeat-containing protein (betaTrCP) in the cytoplasm and provokes the accumulation of beta-catenin and other SCFbetaTrCP substrates, J. Biol. Chem., 2004, 279, 788-95.
45. Karin, M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex, Oncogene, 1999, 18, 6867-74.
46. Peifer, M.; Polakis, P. Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus, Science, 2000, 287, 1606-9.
47. Zhu, Z.; Kirschner, M. Regulated proteolysis of Xom mediates dorsoventral pattern formation during early Xenopus development, Dev. Cell, 2002, 3, 557-68.
48. Margottin-Goguet, F.; Hsu, J.Y.; Loktev, A.; Hsieh, H.M.; Reimann, J.D.; Jackson, P.K. Prophase destruction of Emi1 by the SCF(betaTrCP/Slimb) ubiquitin ligase activates the anaphase promoting complex to allow progression beyond prometaphase, Dev. Cell, 2003, 4, 813-26.
49. Donzelli, M.; Busino, L.; Chiesa, M.; Ganoth, D.; Hershko, A.; Draetta, G.F. Hierarchical order of phosphorylation events commits Cdc25A to betaTrCP-dependent degradation, Cell Cycle, 2004, 3, 469-71.
50. Watanabe, N.; Arai, H.; Nishihara, Y.; Taniguchi, M.; Watanabe, N.; Hunter, T.; Osada, H. M-phase kinases induce phosphodependent ubiquitination of somatic Wee1 by SCFbeta-TrCP, P. Natl. Acad. Sci. USA, 2004, 101, 4419-24.
51. Li, Y.; Kumar, K.G.; Tang, W.; Spiegelman, V.S.; Fuchs, S.Y. Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase, Mol. Cell Biol., 2004, 24, 4038-48.
52. Zhou, B.P.; Deng, J.; Xia, W.; Xu, J.; Li, Y.M.; Gunduz, M.; Hung, M.C. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition, Nat. Cell Biol., 2004, 6, 931-40.
53. Kumar, K.G.; Krolewski, J.J.; Fuchs, S.Y. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor, J. Biol. Chem., 2004, 279, 46614-20.
54. Hu, M.C.; Lee, D.F.; Xia, W.; Golfman, L.S.; Ou-Yang, F.; Yang, J.Y.; Zou, Y.; Bao, S.; Hanada, N.; Saso, H.; Kobayashi, R.; Hung, M.C. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a, Cell, 2004, 117, 225-37.
55. Hayakawa, M.; Kitagawa, H.; Miyazawa, K.; Kitagawa, M.; Kikugawa, K. The FWD1/beta-TrCP-mediated degradation pathway establishes a 'turning off switch' of a Cdc42 guanine nucleotide exchange factor, FGD1, Genes Cells, 2005, 10, 241-51.
56. Eide, E.J.; Woolf, M.F.; Kang, H.; Woolf, P.; Hurst, W.; Camacho, F.; Vielhaber, E.L.; Giovanni, A.; Virshup, D.M. Control of mammalian circadian rhythm by CKIepsilon-regulated proteasomemediated PER2 degradation, Mol. Cell Biol., 2005, 25, 2795-807.
57. Kanemori, Y.; Uto, K.; Sagata, N. Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases, P. Natl. Acad. Sci. USA, 2005, 102, 6279-84.
58. Shirogane, T.; Jin, J.; Ang, X.L.; Harper, J.W. SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-dependent degradation of the mammalian period-1 (Per1) protein, J. Biol. Chem., 2005, 280, 26863-72.
59. Bhatia, N.; Thiyagarajan, S.; Elcheva, I.; Saleem, M.; Dlugosz, A.; Mukhtar, H.; Spiegelman, V.S. Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase, J. Biol. Chem., 2006, 281, 19320-6.
60. Dorrello, N.V.; Peschiaroli, A.; Guardavaccaro, D.; Colburn, N.H.; Sherman, N.E.; Pagano, M. S6K1-and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth, Science, 2006, 314, 467-71.
61. Ray, D.; Osmundson, E.C.; Kiyokawa, H. Constitutive and UVinduced fibronectin degradation is a ubiquitination-dependent process controlled by beta-TrCP, J. Biol. Chem., 2006, 281, 23060-5.
62. Mamely, I.; van Vugt, M.A.; Smits, V.A.; Semple, J.I.; Lemmens, B.; Perrakis, A.; Medema, R.H.; Freire, R. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery, Curr Biol, 2006, 16, 1950-5.
63. Lobry, C.; Lopez, T.; Israel, A.; Weil, R. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10, P. Natl. Acad. Sci. USA, 2007, 104, 908-13.
64. Ding, Q.; He, X.; Hsu, J.M.; Xia, W.; Chen, C.T.; Li, L.Y.; Lee, D.F.; Liu, J.C.; Zhong, Q.; Wang, X.; Hung, M.C. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization, Mol. Cell Biol., 2007, 27, 4006-17.
65. Manavathi, B.; Rayala, S.K.; Kumar, R. Phosphorylationdependent regulation of stability and transforming potential of ETS transcriptional factor ESE-1 by p21-activated kinase 1, J. Biol. Chem., 2007, 282, 19820-30.
66. van Kerkhof, P.; Putters, J.; Strous, G.J. The ubiquitin ligase SCF(betaTrCP) regulates the degradation of the growth hormone receptor, J. Biol. Chem., 2007, 282, 20475-83.
67. Tian, Y.; Kolb, R.; Hong, J.H.; Carroll, J.; Li, D.; You, J.; Bronson, R.; Yaffe, M.B.; Zhou, J.; Benjamin, T. TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex, Mol. Cell Biol., 2007, 27, 6383-95.
68. Reischl, S.; Vanselow, K.; Westermark, P.O.; Thierfelder, N.; Maier, B.; Herzel, H.; Kramer, A. Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics, J. Biol. Rhythms, 2007, 22, 375-86.
69. Setoyama, D.; Yamashita, M.; Sagata, N. Mechanism of degradation of CPEB during Xenopus oocyte maturation, P. Natl. Acad. Sci. USA, 2007, 104, 18001-6.
70. Seki, A.; Coppinger, J.A.; Du, H.; Jang, C.Y.; Yates, J.R., 3rd; Fang, G. Plk1-and beta-TrCP-dependent degradation of Bora controls mitotic progression, J. Cell Biol., 2008, 181, 65-78.
71. Soond, S.M.; Townsend, P.A.; Barry, S.P.; Knight, R.A.; Latchman, D.S.; Stephanou, A. ERK and the F-box protein betaTRCP target STAT1 for degradation, J. Biol. Chem., 2008, 283, 16077-83.
72. Westbrook, T.F.; Hu, G.; Ang, X.L.; Mulligan, P.; Pavlova, N.N.; Liang, A.; Leng, Y.; Maehr, R.; Shi, Y.; Harper, J.W.; Elledge, S.J. SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation, Nature, 2008, 452, 370-4.
73. Lassot, I.; Segeral, E.; Berlioz-Torrent, C.; Durand, H.; Groussin, L.; Hai, T.; Benarous, R.; Margottin-Goguet, F. ATF4 degradation relies on a phosphorylation-dependent interaction with the SCF(betaTrCP) ubiquitin ligase, Mol. Cell Biol., 2001, 21, 2192-202.
74. Ni, F. Recent Developments in Transferred NOE Methods, Progr. Nucl. Mag. Reson. Spectrosc., 1994, 26, 517-606.
75. Verdier, L.; Gharbi-Benarous, J.; Bertho, G.; Mauvais, P.; Girault, J.P. Antibiotic resistance peptides: interaction of peptides conferring macrolide and ketolide resistance with Staphylococcus aureus ribosomes: conformation of bound peptides as determined by transferred NOE experiments, Biochemistry, 2002, 41, 4218-29.
76. Johnson, E.C.; Feher, V.A.; Peng, J.W.; Moore, J.M.; Williamson, J.R. Application of NMR SHAPES screening to an RNA target, J. Am. Chem. Soc., 2003, 125, 15724-5.
77. Bretonnet, A.S. Criblage d'affinité protéine-ligand par RMN et Application à la mise au point d'inhibiteurs de la créatine kinase, PhD Thesis, 2006, Universite Claude Bernard-Lyon 1.
78. Vidal, M.; Liu, W.Q.; Lenoir, C.; Salzmann, J.; Gresh, N.; Garbay, C. Design of peptoid analogue dimers and measure of their affinity for Grb2 SH3 domains, Biochemistry, 2004, 43, 7336-44.
79. England, P.; Bregegere, F.; Bedouelle, H. Energetic and kinetic contributions of contact residues of antibody D1.3 in the interaction with lysozyme, Biochemistry, 1997, 36, 164-72.
80. Vogtherr, M.; Peters, T. Application of NMR based binding assays to identify key hydroxy groups for intermolecular recognition, J. Am. Chem. Soc., 2000, 122, 6093-99.
81. Meyer, B.; Peters, T. NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors, Angew. Chem. Int. Ed. Engl., 2003, 42, 864-90.
82. Clore, G.M.; Gronenborn, A.M. Theory and Applications of the Transferred Nuclear Overhauser Effect to the Study of the Conformations of Small Ligands Bounds to Proteins, J. Magn. Reson., 1982, 48, 402-17.
83. Clore, G.M.; Gronenborn, A.M. Theory of the Time Dependent Transferred Nuclear Overhauser Effect: Applications to Structural Analysis of Ligand-Protein Complexes in Solution, J. Magn. Reson., 1983, 53, 423-42.
84. Moller, H.; Serttas, N.; Paulsen, H.; Burchell, J.M.; Taylor-Papadimitriou, J. NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3, Eur. J. Biochem., 2002, 269, 1444-55.
85. Kooistra, O.; Herfurth, L.; Luneberg, E.; Frosch, M.; Peters, T.; Zahringer, U. Epitope mapping of the O-chain polysaccharide of Legionella pneumophila serogroup 1 lipopolysaccharide by saturation-transfer-difference NMR spectroscopy, Eur. J. Biochem., 2002, 269, 573-82.
86. Johnson, M.A.; Jaseja, M.; Zou, W.; Jennings, H.J.; Copie, V.; Pinto, B.M.; Pincus, S.H. NMR studies of carbohydrates and carbohydrate-mimetic peptides recognized by an anti-group B Streptococcus antibody, J. Biol. Chem., 2003, 278, 24740-52.
87. Kumar, A.; Wagner, G.; Ernst, R.R.; Wüthrich, K. Buildup rates of the NOE measured by 2D Proton Magnetic Resonance Spectroscopy: Implication for studies of protein conformation, J. Am. Chem. Soc., 1981, 103, 3654-58.
88. Nilges, M.; O'Donoghue, S. Ambiguous NOEs and automated NOE assignment, Prog. NMR Spectrosc., 1998, 32, 107-39.
89. Diercks, T.; Coles, M.; Kessler, H. Applications of NMR in drug discovery, Curr. Opin. Chem. Biol, 2001, 5, 285-91.